707 related articles for article (PubMed ID: 7556524)
21. Activation of m3 muscarinic receptors induces rapid tyrosine phosphorylation of p125(FAK), p130(cas), and paxillin in rat pancreatic acini.
Rosado JA; Salido GM; García LJ
Arch Biochem Biophys; 2000 May; 377(1):85-94. PubMed ID: 10775445
[TBL] [Abstract][Full Text] [Related]
22. FAK silencing inhibits leukemogenesis in BCR/ABL-transformed hematopoietic cells.
Le Y; Xu L; Lu J; Fang J; Nardi V; Chai L; Silberstein LE
Am J Hematol; 2009 May; 84(5):273-8. PubMed ID: 19358301
[TBL] [Abstract][Full Text] [Related]
23. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
24. Sequences within the first exon of BCR inhibit the activated tyrosine kinases of c-Abl and the Bcr-Abl oncoprotein.
Liu J; Wu Y; Arlinghaus RB
Cancer Res; 1996 Nov; 56(22):5120-4. PubMed ID: 8912843
[TBL] [Abstract][Full Text] [Related]
25. Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia.
Ebos JM; Tran J; Master Z; Dumont D; Melo JV; Buchdunger E; Kerbel RS
Mol Cancer Res; 2002 Dec; 1(2):89-95. PubMed ID: 12496355
[TBL] [Abstract][Full Text] [Related]
26. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.
Pendergast AM; Quilliam LA; Cripe LD; Bassing CH; Dai Z; Li N; Batzer A; Rabun KM; Der CJ; Schlessinger J
Cell; 1993 Oct; 75(1):175-85. PubMed ID: 8402896
[TBL] [Abstract][Full Text] [Related]
27. Neuromedin B receptor activation causes tyrosine phosphorylation of p125FAK by a phospholipase C independent mechanism which requires p21rho and integrity of the actin cytoskeleton.
Tsuda T; Kusui T; Jensen RT
Biochemistry; 1997 Dec; 36(51):16328-37. PubMed ID: 9405068
[TBL] [Abstract][Full Text] [Related]
28. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
29. BCR/ABL and IL-3 activate Rap1 to stimulate the B-Raf/MEK/Erk and Akt signaling pathways and to regulate proliferation, apoptosis, and adhesion.
Jin A; Kurosu T; Tsuji K; Mizuchi D; Arai A; Fujita H; Hattori M; Minato N; Miura O
Oncogene; 2006 Jul; 25(31):4332-40. PubMed ID: 16518411
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone stimulates tyrosine phosphorylation of focal adhesion kinase (p125(FAK)) and actin stress fiber formation in human osteoblast-like cells, Saos2.
Takahashi MO; Takahashi Y; Iida K; Okimura Y; Kaji H; Abe H; Chihara K
Biochem Biophys Res Commun; 1999 Sep; 263(1):100-6. PubMed ID: 10486260
[TBL] [Abstract][Full Text] [Related]
31. Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death.
Wang Y; Liu J; Wu Y; Luo W; Lin SH; Lin H; Hawk N; Sun T; Guo JQ; Estrov Z; Talpaz M; Champlin R; Arlinghaus RB
Cancer Res; 2001 Jan; 61(1):138-44. PubMed ID: 11196151
[TBL] [Abstract][Full Text] [Related]
32. P210 Bcr-Abl interacts with the interleukin-3 beta c subunit and constitutively activates Jak2.
Wilson-Rawls J; Liu J; Laneuville P; Arlinghaus RB
Leukemia; 1997 Apr; 11 Suppl 3():428-31. PubMed ID: 9209414
[TBL] [Abstract][Full Text] [Related]
33. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL.
Salgia R; Li JL; Lo SH; Brunkhorst B; Kansas GS; Sobhany ES; Sun Y; Pisick E; Hallek M; Ernst T
J Biol Chem; 1995 Mar; 270(10):5039-47. PubMed ID: 7534286
[TBL] [Abstract][Full Text] [Related]
34. Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606.
Mancini M; Brusa G; Zuffa E; Corrado P; Martinelli G; Grafone T; Barbieri E; Santucci MA
Leuk Res; 2007 Jul; 31(7):979-87. PubMed ID: 17129604
[TBL] [Abstract][Full Text] [Related]
35. Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells.
Hallek M; Danhauser-Riedl S; Herbst R; Warmuth M; Winkler A; Kolb HJ; Druker B; Griffin JD; Emmerich B; Ullrich A
Br J Haematol; 1996 Jul; 94(1):5-16. PubMed ID: 8757502
[TBL] [Abstract][Full Text] [Related]
36. T cell receptor engagement induces tyrosine phosphorylation of FAK and Pyk2 and their association with Lck.
Berg NN; Ostergaard HL
J Immunol; 1997 Aug; 159(4):1753-7. PubMed ID: 9257837
[TBL] [Abstract][Full Text] [Related]
37. Phosphospecific antibodies reveal focal adhesion kinase activation loop phosphorylation in nascent and mature focal adhesions and requirement for the autophosphorylation site.
Ruest PJ; Roy S; Shi E; Mernaugh RL; Hanks SK
Cell Growth Differ; 2000 Jan; 11(1):41-8. PubMed ID: 10672902
[TBL] [Abstract][Full Text] [Related]
38. Potential molecules implicated in downstream signaling pathways of p185BCR-ABL in Ph+ ALL involve GTPase-activating protein, phospholipase C-gamma 1, and phosphatidylinositol 3'-kinase.
Gotoh A; Miyazawa K; Ohyashiki K; Toyama K
Leukemia; 1994 Jan; 8(1):115-20. PubMed ID: 8289476
[TBL] [Abstract][Full Text] [Related]
39. A scaffold protein in the c-Jun N-terminal kinase signaling pathway is associated with focal adhesion kinase and tyrosine-phosphorylated.
Takino T; Yoshioka K; Miyamori H; Yamada KM; Sato H
Oncogene; 2002 Sep; 21(42):6488-97. PubMed ID: 12226752
[TBL] [Abstract][Full Text] [Related]
40. Reduced focal adhesion kinase and paxillin phosphorylation in BCR-ABL-transfected cells.
Cheng K; Kurzrock R; Qiu X; Estrov Z; Ku S; Dulski KM; Wang JY; Talpaz M
Cancer; 2002 Jul; 95(2):440-50. PubMed ID: 12124845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
